ACASTI PHARMA INC (ACST)
Institutional ownership reported to the SEC as of Q3 2024, across 5 quarters.
11
Reporting holders
$3.5M
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | $1.9M | 641,083 | 0.54% | 3q | HELD |
| BANK OF AMERICA CORP /DE/ | $1.5M | 494,698 | 0.00% | 5q | HELD |
| RENAISSANCE TECHNOLOGIES LLC | $48.4K | 16,147 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $8.2K | 2,732 | 0.00% | new | NEW |
| NATIONAL BANK OF CANADA /FI/ | $8.1K | 2,719 | 0.00% | 5q | -6.3% |
| MORGAN STANLEY | $5.6K | 1,882 | 0.00% | 5q | HELD |
| Royal Bank of Canada | $2.0K | 543 | 0.00% | 5q | -91.8%-$22.3K |
| Activest Wealth Management | $312 | 104 | 0.00% | 2q | HELD |
| JPMORGAN CHASE & CO | $102 | 34 | 0.00% | 2q | +750.0% |
| UBS Group AG | $84 | 28 | 0.00% | 5q | -99.6%-$23.1K |
| Federation des caisses Desjardins du Quebec | $84 | 28 | 0.00% | 5q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 11 | $3.5M | 1,159,998 | 2 | 1 | 3 | 0.0% |
| Q2 2024 | 12 | $6.3M | 2,152,389 | 3 | 4 | 2 | 0.0% |
| Q1 2024 | 10 | $4.3M | 1,269,196 | 3 | 2 | 2 | 0.0% |
| Q4 2023 | 9 | $1.7M | 573,159 | 2 | 3 | 0 | 0.0% |
| Q3 2023 | 11 | $1.6M | 558,306 | 11 | 0 | 0 | 0.0% |